Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin-Reference-Cited by-同舟云学术

Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin

Published:2018-11 Issue:5 Volume:268 Page:845-853
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Schneider Marcel André,Eden Janina,Pache Basile,Laminger Felix,Lopez-Lopez Victor,Steffen Thomas,Hübner Martin,Kober Friedrich,Roka Sebastian,Campos Pedro Cascales,Roth Lilian,Gupta Anurag,Siebenhüner Alexander,Kepenekian Vahan,Passot Guillaume,Gertsch Philippe,Glehen Olivier,Lehmann Kuno

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference40 articles.

1. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database;Franko;Lancet Oncol,2016

2. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia;Glehen;Lancet Oncol,2004

3. Where oncologic and surgical complication scoring systems collide: time for a new consensus for CRS/HIPEC;Lehmann;World J Surg,2016

4. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study;Goéré;Ann Surg Oncol,2015

5. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study;Elias;J Clin Oncol,2010

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II);European Journal of Surgical Oncology;2024-09

2. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-09

3. Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2024-08-11

4. Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data;Clinical Colorectal Cancer;2024-05

5. Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases;ESMO Open;2024-04